Sun Pharma plans ₹10,000 crore bond sale to refinance Organon acquisition loan: Report
· livemint.com
The country's largest drugmaker by market capitalisation closed a syndication of a near-$12 billion, 18-month bridge loan earlier this year for Organon's acquisition. The syndication also included State Bank of India, the country's largest lender by assets.
India's Sun Pharmaceutical Industries is planning to raise around 100 billion rupees ($1.04 billion) via a rupee-denominated debt sale to partly fund a bridge l...